Although metabolic differences were not clearly identified at the mRNA or protein level in glycolytic enzymes, the metabolic data indicate that glycolysis capacity was decreased in the lung cancer cells with acquired EGFR-TKI resistance. Here, EGFR is linked to lung cancer.